Remove solutions timely-targeted-interventions
article thumbnail

Tapping into pharma’s growing opportunities in digital health

Pharmaceutical Technology

Pharma, which is already growing its role in delivering hybrid solutions combining therapies with diagnostic and smart solutions and devices, could play a significant role here, providing smart end-to-end solutions and data-related tools that transcend the immediate treatment. Breaking down the opportunities.

article thumbnail

Vaccine successfully lowers cholesterol in preclinical studies

Drug Discovery World

VXX-401 is a synthetic peptide vaccine designed to stimulate the immune system to produce antibodies targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), which reduce circulating LDL-C by inhibiting the breakdown of low density lipoprotein receptor (LDLR).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Innovations in Heart Failure Management Through Cardiovascular Device Development

XTalks

Lubert, MD, Medical Director of the Medical Department at Medpace, discussed new interventions for heart failure, showcasing devices for reverse remodeling and shunt devices. Kereiakes discussed the prevalence of valvular heart disease and shared insights into catheter-based interventions targeting aortic, mitral and tricuspid valves.

article thumbnail

Roche extends Kaiku digital monitoring partnership again

pharmaphorum

The two companies have been working together since 2019 on digital health interventions to provide support to people with cancer, focusing initially on tools for patients undergoing cancer immunotherapy. Lauri Sippola. ” The post Roche extends Kaiku digital monitoring partnership again appeared first on.

Nurses 135
article thumbnail

Empowering Clinical Trials: The Vital Role of Risk-Based Monitoring in EDC

Cloudbyz

This targeted approach not only reduces the burden on stakeholders but also enhances data quality by focusing on critical data points. One of the standout features of Cloudbyz EDC is its robust RBM capabilities, which enable early issue detection and intervention.

article thumbnail

3D Heart Modeling Solution By inHEART Gets FDA Clearance

XTalks

A new 3D heart modeling solution by inHEART received FDA 510(k) clearance. The modeling solution allows for 3D visualization and analysis of the heart for pre-procedural planning and intraprocedural use. “We have been using the inHEART solution in clinical research for several years. Photo courtesy of inHEART.

article thumbnail

Ogsiveo Receives FDA Approval as First Therapy for Desmoid Tumors

XTalks

Treatment guidelines now recommend systemic therapies as first-line interventions instead of surgery for most tumor cases. As an inhibitor of gamma secretase, Ogsiveo can prevent cleavage of BCMA receptors on the surface of tumor cells, which can increase BCMA target density for drugs.